Djursun Karasartova1, Umut Gazi2, Ozgur Tosun3, Ayse S Gureser1, Ibrahim T Sahiner4, Mete Dolapci4, Aysegul T Ozkan1. 1. Department of Medical Microbiology, Faculty of Medicine, Hitit University, Corum, Turkey. 2. Department of Medical Microbiology and Clinic Microbiology, Faculty of Medicine, Near East University, Near East Boulevard, Nicosia, Cyprus. umut.gazi@neu.edu.tr. 3. Department of Biostatistics, Faculty of Medicine, Near East University, Nicosia, Cyprus. 4. Department of General Surgery, Faculty of Medicine, Hitit University, Corum, Turkey.
Abstract
PURPOSE: Splenectomy is associated with increased risk of overwhelming post-splenectomy infections despite proper anti-pneumococcal vaccination. As most studies concentrated on vaccination-induced humoral immunity, the cellular immune responses triggered in splenectomized patients are not yet well studied. The present study aims to investigate this area as it can contribute to the development of more effective vaccination strategies. METHODS: Five healthy and 14 splenectomized patients were vaccinated with pneumococcal conjugate polysaccharide vaccine (PCV) followed by pneumococcal polysaccharide vaccine according to the guidelines established by Advisory Committee on Immunization Practices. PBMC samples collected 0, 8, and 12 weeks after PCV immunization were in vitro stimulated with PCV. Levels of lymphoproliferation, TH cell differentiation, and cytokine release were assessed by carboxyfluorescein succinimidyl ester labeling, intracellular cytokine staining, and ELISA, respectively. RESULTS: While TH1-dominated immune response was detected in both groups, asplenic individuals generated significantly lower levels of TH1 cells following in vitro stimulation. Similarly, levels of IFN-γ, IL-4, and IL-17 release and lymphoproliferation were significantly lower in asplenic patients. CONCLUSIONS: According to our data, splenectomy negatively influences the levels of PCV-induced lymphoproliferation, TH1 differentiation, and cytokine release. Besides, PCV failed to induce TH17-dominant immune response which is crucial for protection against extracellular pathogens.
PURPOSE: Splenectomy is associated with increased risk of overwhelming post-splenectomy infections despite proper anti-pneumococcal vaccination. As most studies concentrated on vaccination-induced humoral immunity, the cellular immune responses triggered in splenectomized patients are not yet well studied. The present study aims to investigate this area as it can contribute to the development of more effective vaccination strategies. METHODS: Five healthy and 14 splenectomized patients were vaccinated with pneumococcal conjugate polysaccharide vaccine (PCV) followed by pneumococcalpolysaccharide vaccine according to the guidelines established by Advisory Committee on Immunization Practices. PBMC samples collected 0, 8, and 12 weeks after PCV immunization were in vitro stimulated with PCV. Levels of lymphoproliferation, TH cell differentiation, and cytokine release were assessed by carboxyfluorescein succinimidyl ester labeling, intracellular cytokine staining, and ELISA, respectively. RESULTS: While TH1-dominated immune response was detected in both groups, asplenic individuals generated significantly lower levels of TH1 cells following in vitro stimulation. Similarly, levels of IFN-γ, IL-4, and IL-17 release and lymphoproliferation were significantly lower in asplenic patients. CONCLUSIONS: According to our data, splenectomy negatively influences the levels of PCV-induced lymphoproliferation, TH1 differentiation, and cytokine release. Besides, PCV failed to induce TH17-dominant immune response which is crucial for protection against extracellular pathogens.
Authors: Ying-Jie Lu; Jane Gross; Debby Bogaert; Adam Finn; Linda Bagrade; Qibo Zhang; Jay K Kolls; Amit Srivastava; Anna Lundgren; Sophie Forte; Claudette M Thompson; Kathleen F Harney; Porter W Anderson; Marc Lipsitch; Richard Malley Journal: PLoS Pathog Date: 2008-09-19 Impact factor: 6.823
Authors: Guzman Sanchez-Schmitz; Chad R Stevens; Ian A Bettencourt; Peter J Flynn; Klaus Schmitz-Abe; Gil Metser; David Hamm; Kristoffer J Jensen; Christine Benn; Ofer Levy Journal: Front Immunol Date: 2018-11-20 Impact factor: 7.561
Authors: Anja Gäckler; Nils Mülling; Kim Völk; Benjamin Wilde; Ute Eisenberger; Hana Rohn; Peter A Horn; Oliver Witzke; Monika Lindemann Journal: Vaccines (Basel) Date: 2021-12-06